Jenise Solomons Butler Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 102 Main St, Gleason, TN 38229 Phone: 731-648-5146 |
Ms. Kim R Sturgeon Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 102 Main St, Gleason, TN 38229 Phone: 731-648-5146 Fax: 731-648-5524 |
Ms. Krista R. Morse, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 102 Main St, Gleason, TN 38229 Phone: 731-648-5146 Fax: 731-648-5524 |
News Archive
Targacept, Inc. today announced the presentation of data from a Phase 2 clinical proof of concept trial to assess TC-5619 as an augmentation therapy to improve cognition in patients with schizophrenia at the International Congress on Schizophrenia Research in Colorado Springs, Colorado.
Transient receptor potential channel A1 is one of the important transducers of noxious stimuli in the primary afferents, which may contribute to generation of neurogenic inflammation and hyperalgesia.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that Novartis has elected to fully exercise its current right to purchase 55,223 unregistered shares of Alnylam's common stock in accordance with the terms of the Investor Rights Agreement between Alnylam and Novartis, dated September 6, 2005.
Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.
› Verified 3 days ago